Immediate Impact

4 by Nobel laureates 8 from Science/Nature 53 standout
Sub-graph 1 of 24

Citing Papers

Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
2025 Standout
Therapeutic advances in rheumatoid arthritis
2024 Standout

Works of Laurence Colin being referenced

First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody
2019
A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery disease
2019

Author Peers

Author Last Decade Papers Cites
Laurence Colin 369 360 252 264 36 984
S Santambrogio 304 268 102 306 36 1.2k
H.J. Schuurman 344 111 397 95 45 925
P. T. A. Schellekens 157 237 486 228 40 1.0k
Truman Grayson 252 339 130 219 16 936
William Farrugia 481 80 303 79 44 1.1k
Sachin Gupta 119 188 308 98 47 933
O Picard 140 300 182 242 47 1.0k
E. Hammond 204 452 27 391 38 980
James H. Pert 238 178 142 93 34 1.0k
Maria Cristina Gauzzi 285 150 648 114 31 1.2k

All Works

Loading papers...

Rankless by CCL
2026